Enter the first few characters of Company and click 'Go'
Aurobindo Pharma Ltd. Company Financial Ratios Analysis
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
|
PER SHARE RATIOS |
Adjusted EPS (Rs.) |
21.00 |
26.10 |
53.13 |
31.96 |
26.11 |
Adjusted Cash EPS (Rs.) |
28.43 |
33.19 |
61.46 |
39.99 |
33.16 |
Reported EPS (Rs.) |
21.00 |
24.83 |
53.13 |
31.96 |
26.11 |
Reported Cash EPS (Rs.) |
28.43 |
31.91 |
61.46 |
39.99 |
33.16 |
Dividend Per Share |
3.00 |
9.00 |
4.00 |
3.00 |
2.50 |
Operating Profit Per Share (Rs.) |
29.54 |
25.15 |
70.31 |
45.84 |
41.12 |
Book Value (Excl Rev Res) Per Share (Rs.) |
305.73 |
292.14 |
271.78 |
222.30 |
193.72 |
Book Value (Incl Rev Res) Per Share (Rs.) |
305.73 |
292.14 |
271.78 |
222.30 |
193.72 |
Net Operating Income Per Share (Rs.) |
218.32 |
192.63 |
270.06 |
226.41 |
209.21 |
Free Reserves Per Share (Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
PROFITABILITY RATIOS |
Operating Margin (%) |
13.53 |
13.05 |
26.03 |
20.24 |
19.65 |
Adjusted Cash Margin (%) |
12.59 |
16.26 |
21.93 |
17.14 |
15.59 |
Adjusted Return On Net Worth (%) |
6.86 |
8.93 |
19.54 |
14.37 |
13.47 |
Reported Return On Net Worth (%) |
6.86 |
8.49 |
19.54 |
14.37 |
13.47 |
Return On long Term Funds (%) |
9.65 |
10.10 |
26.51 |
20.10 |
19.34 |
|
LEVERAGE RATIOS |
Long Term Debt / Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Owners fund as % of total Source |
81.21 |
90.39 |
80.11 |
77.73 |
71.52 |
Fixed Assets Turnover Ratio |
0.62 |
0.58 |
0.86 |
0.81 |
0.83 |
|
LIQUIDITY RATIOS |
Current Ratio |
4.44 |
4.20 |
3.92 |
4.29 |
4.78 |
Current Ratio (Inc. ST Loans) |
1.15 |
1.78 |
1.16 |
1.16 |
0.96 |
Quick Ratio |
3.01 |
2.95 |
2.46 |
2.74 |
3.04 |
Fixed Assets Turnover Ratio |
0.62 |
0.58 |
0.86 |
0.81 |
0.83 |
|
PAYOUT RATIOS |
Dividend payout Ratio (Net Profit) |
26.38 |
14.10 |
6.50 |
7.50 |
7.53 |
Dividend payout Ratio (Cash Profit) |
26.38 |
14.10 |
6.50 |
7.50 |
7.53 |
Earning Retention Ratio |
64.29 |
82.77 |
92.48 |
90.62 |
90.43 |
Cash Earnings Retention Ratio |
73.62 |
86.45 |
93.50 |
92.50 |
92.47 |
|
COVERAGE RATIOS |
Adjusted Cash Flow Time Total Debt |
2.49 |
0.94 |
1.10 |
1.59 |
2.33 |
Financial Charges Coverage Ratio |
18.83 |
126.59 |
164.22 |
12.82 |
11.30 |
Fin. Charges Cov.Ratio (Post Tax) |
15.49 |
111.39 |
126.55 |
10.73 |
9.42 |
|
COMPONENT RATIOS |
Material Cost Component(% earnings) |
58.44 |
52.58 |
46.90 |
52.17 |
54.27 |
Selling Cost Component |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Exports as percent of Total Sales |
66.82 |
68.43 |
84.33 |
80.98 |
79.39 |
Import Comp. in Raw Mat. Consumed |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Long term assets / Total Assets |
0.48 |
0.48 |
0.44 |
0.39 |
0.40 |
Bonus Component In Equity Capital (%) |
79.45 |
79.45 |
79.45 |
79.45 |
79.45 |